On February 12, 2025, the United States District Court for the District of Delaware denied defendant Parse Biosciences’s (“Parse”) motions for ...
All virtual and in-person submissions will be required to upload their poster and a 5–10-minute narrative recording and on VoiceThread. During the in-person presentations on Symposium Day, the top ...
Feb. 28, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today ...